Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
135.00    3.40 (2.58%)
Bid:
134.90
Ask:
135.20
Spread: 0.30 (0.222%)
Market Cap: £341.40m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Directorate Change

31 Mar 2017 07:00

RNS Number : 0931B
Marshalls PLC
31 March 2017
 

 

31 March 2017

 

Directorate Changes

 

Marshalls plc ("Marshalls" or "the Company") is pleased to announce the appointment of Graham Prothero to the Board as a non-executive director, which will take effect immediately after the Annual General Meeting ("AGM") of Marshalls plc on 10 May 2017.

 

Mark Edwards, non-executive Director and Chair of the Audit Committee, who has served on the Board since May 2010, has announced his intention to retire from the Board following the close of the AGM on 10 May 2017. It is expected that Graham Prothero will succeed Mark Edwards as Chair of the Audit Committee upon Mark's retirement.

 

Graham Prothero is a Chartered Accountant and is an Executive Director and Group Chief Financial Officer of Galliford Try plc, the industry-leading FTSE 250 housebuilding, regeneration and construction group. He is also Non-Executive Deputy Chair of the Jigsaw Trust, a charitable trust. Prior to joining Galliford Try plc in 2013, he was Group Finance Director at leading property developer Development Securities PLC (now U+I), having previously held senior finance positions at Taylor Woodrow, the FTSE 100 listed housebuilder, and at Blue Circle Industries plc. Graham also spent 7 years as a partner in the Real Estate, Hospitality and Construction Group of Ernst & Young LLP. He brings current and relevant financial experience in the construction and building materials sector, as well as wider experience in an advisory professional capacity in relation to businesses operating in construction, real estate and other sectors.

 

The recruitment of Graham Prothero to succeed Mark Edwards takes place in line with the Company's Board development and succession planning strategy to regularly refresh the skills and experience around the Board table, and followed a formal, rigorous and objective process led by the Nomination Committee with the help of external consultants Lygon.

 

Andrew Allner, Chairman of Marshalls, commented: "I am delighted that Graham Prothero will be joining the Board as a non-executive director to succeed Mark Edwards. He brings broad financial and relevant sector experience and will be a valuable addition to the Board. I would also like to express our thanks to Mark Edwards, who is stepping down after 7 years' service on the Marshalls Board and as Chair of the Audit Committee. Mark's contribution to the Board and the Company is greatly appreciated".

 

Enquiries:

Andrew Allner - Chairman (Tel: 01422 314777)

Martyn Coffey - Chief Executive (Tel: 01422 314777)

Andrew Jaques / James White / Charlie Barker - MHP (Tel: 0203 128 8540)

 

Additional information:

Graham Prothero is independent for the purposes of the UK Corporate Governance Code This announcement includes the information required by Listing Rules 9.6.11 to 9.6.13, and there is no information to report under Listing Rule 9.6.13 (2) - (6) inclusive.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAURRBRBVAOOAR
Date   Source Headline
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 202612:17 pmRNSHolding(s) in Company
22nd May 20264:01 pmRNSDirector/PDMR Shareholding
22nd May 20263:58 pmRNSDirector/PDMR Shareholding
15th May 202611:04 amRNSDirector/PDMR Shareholding
15th May 202611:03 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
13th May 20263:08 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
15th Apr 202612:17 pmRNSDirector/PDMR Shareholding
15th Apr 202612:15 pmRNSDirector/PDMR Shareholding
17th Mar 20263:01 pmRNSDirector/PDMR Shareholding
17th Mar 20262:59 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSFinal Results
16th Mar 20267:00 amRNSFinal Results
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RNotice of Engage Investor Presentation
13th Feb 20263:21 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
19th Jan 20267:01 amRNSTrading Statement
19th Jan 20267:00 amRNSDirectorate change
9th Jan 202612:40 pmRNSDirector/PDMR Shareholding
9th Jan 202612:38 pmRNSDirector/PDMR Shareholding
6th Jan 20269:36 amRNSNotice of Trading Update
9th Dec 20253:21 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSBoard changes
12th Nov 20257:00 amRNSTrading Update
10th Nov 202510:30 amRNSDirector/PDMR Shareholding
10th Nov 202510:29 amRNSDirector/PDMR Shareholding
10th Nov 202510:27 amRNSDirector/PDMR Shareholding
30th Oct 20259:01 amRNSNotice of Trading Update
9th Oct 202512:45 pmRNSDirector/PDMR Shareholding
9th Oct 202512:44 pmRNSDirector/PDMR Shareholding
9th Oct 202512:42 pmRNSDirector/PDMR Shareholding
10th Sep 202512:06 pmRNSDirector/PDMR Shareholding
10th Sep 202512:05 pmRNSDirector/PDMR Shareholding
10th Sep 202512:04 pmRNSDirector/PDMR Shareholding
12th Aug 20259:28 amRNSDirector/PDMR Shareholding
11th Aug 20251:57 pmRNSDirector/PDMR Shareholding
11th Aug 20257:00 amRNSHalf year results
7th Aug 20257:00 amRNSDirectorate Change
28th Jul 202512:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.